ADC Therapeutics SA (ADCT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,386
Total Return
-86.14%
CAGR
-32.65%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.34% |
| Median | -5.19% |
| Best | +235.99% |
| Worst | -53.07% |
| % of Windows Positive | 39.8% |
1-Year (252 Trading Days)
| Average | +12.46% |
| Median | -30.66% |
| Best | +536.75% |
| Worst | -88.70% |
| % of Windows Positive | 44.3% |
3-Year (756 Trading Days)
| Average | -44.82% |
| Median | -65.77% |
| Best | +117.41% |
| Worst | -92.58% |
| % of Windows Positive | 19.4% |
Risk Metrics
| Maximum Drawdown | -98.51% |
| Average Drawdown | -77.75% |
| Drawdown Duration | 1150 Trading Days (Unrecovered) |
| Sortino Ratio | 0.07 |
| Calmar Ratio | -0.33 |
| CVaR (5%) | -11.39% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -12.75% (-27.63% ann.) | $1274.78 | $0.00 | $0.00 | $0.00 |
| 2025 | +77.39% | +$7738.83 | $0.00 | $0.00 | $0.00 |
| 2024 | +19.88% | +$1987.96 | $0.00 | $0.00 | $0.00 |
| 2023 | -56.77% | $5677.11 | $0.00 | $0.00 | $0.00 |
| 2022 | -80.99% | $8099.01 | $0.00 | $0.00 | $0.00 |
| 2021 | -36.89% | $3689.48 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +6.70% (+11.00% ann.) | +$670.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | May 18, 2020 – November 6, 2020 | +8.33% | +18.53% | +$833.33 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -34.53% | -33.09% | $3452.63 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -81.99% | -83.80% | $8198.56 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -22.00% | -12.55% | $2199.98 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -0.64% | -0.38% | $64.45 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.